Novo Nordisk’s lawsuit against Eli Lilly over ads highlights intense competition in GLP-1 market
At a glance
The Danish company Novo Nordisk says U.S.-based Lilly isn’t including the most up-to-date clinical information about its drugs.
- Primary source
- MarketWatch.com - Top Stories — Read original article
- Published
- Topic
- Finance
The Danish company Novo Nordisk says U.S.-based Lilly isn’t including the most up-to-date clinical information about its drugs.
This summary comes from MarketWatch.com - Top Stories. Read the full article at the original source.
References
More in Finance
Goldman traders are on pace for a record year. A close-up look at how they're doing it
In a new interview with CNBC, a Goldman exec breaks down what's driving stocks, where markets are headed, and how the bank’s equities desk fuels its growth.
Let’s elect candidates who will make the wealthy pay taxes
We can use some of those revenues to make Social Security contributions more equitable.
‘Don’t get suckered like I did’: I paid $185 to the wrong passport website. Can I get my money back?
“I will file a complaint with the Better Business Bureau.”
Rising Medicare Part D premiums could drive more people into Medicare Advantage plans
Medicare Advantage plans could be the winners of a decision by the Trump administration to put an early end to a program that kept the cost of Medicare prescription drug plans…